Doctor sounds alarm on quality, efficacy of Alzheimer’s supplement
By
Kristen Fischer
Feb 27, 2024
When it was sold as a prescription generic drug, galantamine was labeled accurately and it wasn’t contaminated. But that wasn’t the case when galantamine was sold as an over-the-counter dietary supplement,...
Not all older adults can get monoclonal antibodies for Alzheimer’s disease, study finds
By
Kristen Fischer
Sep 22, 2023
Even though newer monoclonal antibodies are available for Alzheimer’s disease, there are limits on the number of older adults who can receive them, a recent study published in Neurology finds.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Physical therapy group opposes proposed 3.6% reimbursement cut
By
Kristen Fischer
Sep 14, 2023
The Alliance for Physical Therapy Quality and Innovation (APTQI) called on the Centers for Medicare & Medicaid Services to revisit its Medicare doctor fee proposal for next year, saying the changes could...
Industry advocates have launched an online platform and forum open to all LTC staff who perform infection prevention and control duties.
Simple interventions can greatly reduce residents’ falls
By
Alicia Lasek
Sep 23, 2019
Fatal falls have nearly tripled among older Americans, and experts are calling for stepped-up prevention measures such as these.
U.S., Canada ‘not that different’ in LTC staff response to pandemic work conditions: study
By
Alicia Lasek
Feb 19, 2021
“We talk about how great Canada’s healthcare system is vis-à-vis that of the United States … but we are not that different when it comes to long-term care,” the researchers say.
AHA’s new heart-health dietary advice highlights personal patterns, style
By
Alicia Lasek
Nov 23, 2021
The emphasis is now on dietary patterns, not specific foods or nutrients, the lead author says. “And it’s not just about what people shouldn’t be eating.”
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
U.S. COVID-19 strategy must veer to protecting the vulnerable, experts say
By
Alicia Lasek
Mar 22, 2022
When planning for a future with COVID-19, some clinicians believe that the public health focus should turn from stopping transmission to protecting those most likely to become severely ill, according to...